[Therapeutic cloning. Biology, perspectives and alternatives].
Certain diseases are caused by or cause irreversible loss of cells and may in the future be treated by cell-based therapies where spare cells are introduced into the body. Therapeutic cloning constitutes a scientifically and ethically challenging route to the generation of autologous patient specific spare cells: Stem cells for subsequent differentiation and transplantation are isolated from one week old embryos, which are produced by cloning by nuclear transfer from normal cells retrieved from a patient. Research in therapeutic cloning should be pursued in line with alternative strategies for obtaining stem cells. Finally, the molecular biology of cloning by nuclear transfer may hold the key to understanding trans-differentiation, which ultimately may allow for de-differentiation and subsequent re-differentiation of adult somatic cells for therapeutic purposes.
Maddox-Hyttel
Poul
P
Institut for Anatomi og Fysiologi, Den Kgl. Veterinaer- og Landbohøjskole, Grønnegaardsvej 7, DK-1870 Frederiksberg C.
D000328:Adult; D000818:Animals; D002454:Cell Differentiation; D019976:Cloning, Organism; D006801:Humans; D053652:Nuclear Transfer Techniques; D033581:Stem Cell Transplantation